United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-3268_4c3bfaa1-85d5-5e53-e063-6294a90a84fd
- Product NDC
- 68071-3268
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070627
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-1) · 68071-3268-1
- 2 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-2) · 68071-3268-2
- 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-3) · 68071-3268-3
- 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-4) · 68071-3268-4
- 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-5) · 68071-3268-5
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-6) · 68071-3268-6
- 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-7) · 68071-3268-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →